Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

Optimal first-line immune checkpoint inhibitor...

Journal article

Optimal first-line immune checkpoint inhibitor treatment in lung cancer: how to choose?

Authors

Kartolo A; Robinson A; Fung AS

Journal

Future Oncology, Vol. 18, No. 6, pp. 635–638

Publisher

Taylor & Francis

Publication Date

February 2022

DOI

10.2217/fon-2021-1348

ISSN

1479-6694

Associated Experts

Adi Kartolo

Assistant Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Carcinoma, Non-Small-Cell Lung Clinical Decision-Making Humans Immune Checkpoint Inhibitors Lung Neoplasms Neoplasm Metastasis

View published work (Non-McMaster Users)

View published work (McMaster Users)